The development and validation of models of human skin diseases for drug testing

Completed

• Conditions: Developing human skin disease models; atopic dermatitis; psoriasis; vitiligo; 10047043

• Registration Number: NL-OMON38558
• Lead Sponsor: Derphartox

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 36

Inclusion Criteria

Volunteers (male/female) are 18 years or older, suffering from psoriasis vulgaris, vitiligo or atopic dermatitis.

Exclusion Criteria

Volunteers cannot be taking immune-modulating drugs.
Volunteers cannot have UV/light therapy.
If donating lesional skin biopsies then patients cannot use topical treatments up to 2 weeks before donating the biopsies (they can use placebo creams to treat dry skin).
Volunteers should not have problems with the Köbner phenomenom.
Volunteers should not be pregnant

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>N.A.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>N.A.</p><br>